4. Maverakis E, Wang E, Shinkai K, Mahasirimongkol S, Margolis D, Avigan M et al. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Standard Reporting and Evaluation Guidelines. JAMA Dermatology. 2017;153(6):587.
5. Cohen v. Toxic Epidermal Necrolysis (TEN): Background, Pathophysiology, Etiology Medscape, 2018. Available from: https://emedicine.medscape.com/article/229698-overview
7. Frey N, Jossi J, Bodmer M, Bircher A, Jick S, Meier C et al. The Epidemiology of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in the UK. Journal of Investigative Dermatology. 2017;137(6):1240-1247.
8. Yang S, Hu S, Zhang S, Huang J, Zhang J, Ji C et al. The Epidemiology of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in China. Journal of Immunology Research. 2018;2018:1-10.
9. Rahmawati Y, Indramaya D. Studi Retrospektif: Sindrom Stevens-Johnson dan Toxic epidermal necrolysis. Berkala Ilmu Kesehatan Kulit dan Kelamin – Periodical of Dermatology and Venereology. 2016;28(2):68-76.
10. Mochtar M, Negara W, Murasmita A. Angka Kejadian Sindrom Stevens-Johnson dan Toxic epidermal necrolysis di RS Dr. Moewardi Surakarta Periode Agustus 2011-Agustus 2013. Media Dermato-Venereologica Indonesiana. 2015;42(2):65-69.
15. Yang MS, Lee JY, Kim J, et al. Incidence of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Nationwide Population-Based Study Using National Health Insurance Database in Korea. PLoS One. 2016;11(11):e0165933. doi:10.1371/journal.pone.0165933